CompletedNCT06801158
Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase
Observational studyFrance
Understand this study
- Listed locations
- CaenSee all locations and recruitment
Study information
Study start dateStarted: November 1, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8,804,863
- Sponsor
- University Hospital, Caen
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- Not clearly listed
- Official registry ID
- NCT06801158
- Official title
Show the full official title
Adverse Drug Reactions to Cancer Therapies in Patients with Depression: Insights from VigiBase
Get this study by email
Recruitment & locations
CompletedCaen
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Caen, a hospital or academic medical center.
